| scholarly article | Q13442814 |
| P2093 | author name string | Sanjay K Singh | |
| Alok Agrawal | |||
| Avinash Thirumalai | |||
| Asmita Pathak | |||
| Donald N Ngwa | |||
| P2860 | cites work | C-reactive protein-bound enzymatically modified low-density lipoprotein does not transform macrophages into foam cells | Q24321501 |
| Human L-ficolin recognizes phosphocholine moieties of pneumococcal teichoic acid | Q27695732 | ||
| A staggered decameric assembly of human C-reactive protein stabilized by zinc ions revealed by X-ray crystallography | Q27697272 | ||
| Three dimensional structure of human C-reactive protein | Q27732605 | ||
| C-reactive protein is essential for innate resistance to pneumococcal infection | Q33842663 | ||
| Cell signaling by reactive nitrogen and oxygen species in atherosclerosis | Q34006311 | ||
| C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids | Q34191416 | ||
| Identification of acidic pH-dependent ligands of pentameric C-reactive protein | Q34285524 | ||
| Obesity associated molecular forms of C-reactive protein in human | Q34316624 | ||
| Oxidative stress sensitizes retinal pigmented epithelial (RPE) cells to complement-mediated injury in a natural antibody-, lectin pathway-, and phospholipid epitope-dependent manner | Q34620560 | ||
| Atherosclerosis-Related Functions of C-Reactive Protein | Q35073552 | ||
| C-reactive protein protects mice against pneumococcal infection via both phosphocholine-dependent and phosphocholine-independent mechanisms | Q35439657 | ||
| An acidic microenvironment sets the humoral pattern recognition molecule PTX3 in a tissue repair mode | Q35671242 | ||
| Exposing a hidden functional site of C-reactive protein by site-directed mutagenesis | Q35728529 | ||
| Streptococcus pneumoniae secretes hydrogen peroxide leading to DNA damage and apoptosis in lung cells | Q35818866 | ||
| Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia | Q35963030 | ||
| Selective Targeting of a Disease-Related Conformational Isoform of Macrophage Migration Inhibitory Factor Ameliorates Inflammatory Conditions. | Q35979041 | ||
| Studies of acute phase protein. I. An immunohistochemical method for the localization of Cx-reactive protein in rabbits. Association with necrosis in local inflammatory lesions | Q36334412 | ||
| Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein | Q36346658 | ||
| The pro-atherogenic effects of macrophages are reduced upon formation of a complex between C-reactive protein and lysophosphatidylcholine | Q36423484 | ||
| Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury | Q36732994 | ||
| C-reactive protein/oxidised low-density lipoprotein/β2-glycoprotein I complex promotes atherosclerosis in diabetic BALB/c mice via p38mitogen-activated protein kinase signal pathway | Q36814928 | ||
| Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein | Q36860930 | ||
| An Intrinsically Disordered Motif Mediates Diverse Actions of Monomeric C-reactive Protein | Q36884724 | ||
| Redox regulation in the extracellular environment | Q37045097 | ||
| Multifaceted anti-amyloidogenic and pro-amyloidogenic effects of C-reactive protein and serum amyloid P component in vitro. | Q37067700 | ||
| Interaction of calcium-bound C-reactive protein with fibronectin is controlled by pH: in vivo implications | Q37285802 | ||
| The vicious circle between oxidative stress and inflammation in atherosclerosis. | Q37334949 | ||
| The binding of C-reactive protein, in the presence of phosphoethanolamine, to low-density lipoproteins is due to phosphoethanolamine-generated acidic pH. | Q37416223 | ||
| Roles of oxidative stress and redox regulation in atherosclerosis | Q37596240 | ||
| Recognition functions of pentameric C-reactive protein in cardiovascular disease | Q38221846 | ||
| Probing the C1q-binding site on human C-reactive protein by site-directed mutagenesis | Q38307556 | ||
| Collagen-induced arthritis is exacerbated in C-reactive protein-deficient mice | Q38341672 | ||
| C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance | Q38596519 | ||
| The Carbohydrate-linked Phosphorylcholine of the Parasitic Nematode Product ES-62 Modulates Complement Activation. | Q38863991 | ||
| A conformational change of C-reactive protein in burn wounds unmasks its proinflammatory properties | Q38993371 | ||
| Sustained submicromolar H2O2 levels induce hepcidin via signal transducer and activator of transcription 3 (STAT3). | Q39288648 | ||
| Pathophysiological condition changes the conformation of a flexible FBG-related protein, switching it from pathogen-recognition to host-interaction | Q39521307 | ||
| Factor H-related protein 5 interacts with pentraxin 3 and the extracellular matrix and modulates complement activation | Q40161972 | ||
| The factor H variant associated with age-related macular degeneration (His-384) and the non-disease-associated form bind differentially to C-reactive protein, fibromodulin, DNA, and necrotic cells | Q40172276 | ||
| Regulation of complement activation by C-reactive protein: targeting of the inhibitory activity of C4b-binding protein | Q40271737 | ||
| Streptococcus oralis Induces Lysosomal Impairment of Macrophages via Bacterial Hydrogen Peroxide | Q40699809 | ||
| Interaction of C-reactive protein with artificial phosphatidylcholine bilayers | Q41752082 | ||
| Effect of CRP on Some of the in vitro Physicochemical Properties of LDL | Q41971745 | ||
| C-reactive protein exists in an NaCl concentration-dependent pentamer-decamer equilibrium in physiological buffer | Q41986528 | ||
| Complement factor H binds to denatured rather than to native pentameric C-reactive protein | Q42043743 | ||
| Macrophage uptake of low-density lipoprotein bound to aggregated C-reactive protein: possible mechanism of foam-cell formation in atherosclerotic lesions | Q43002113 | ||
| Gain of function of immunoglobulins after partial unfolding or cofactor binding | Q44212984 | ||
| Lectin specificity and binding characteristics of human C-reactive protein | Q44393824 | ||
| Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence | Q44810016 | ||
| C-reactive protein inhibits in vitro oxidation of low-density lipoprotein. | Q44923160 | ||
| Defined chemically cross-linked oligomers of human C-reactive protein: characterization and reactivity with the complement system | Q45118568 | ||
| Monomeric C-reactive protein decreases acetylated LDL uptake in human endothelial cells | Q46243550 | ||
| Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer? | Q46513399 | ||
| Effect of modified C-reactive protein on complement activation: a possible complement regulatory role of modified or monomeric C-reactive protein in atherosclerotic lesions | Q46925904 | ||
| ATP modulates acute inflammation in vivo through dual oxidase 1-derived H2O2 production and NF-κB activation. | Q47074216 | ||
| C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease | Q48796828 | ||
| Dissociation of pentameric to monomeric C-reactive protein localizes and aggravates inflammation: in vivo proof of a powerful proinflammatory mechanism and a new anti-inflammatory strategy. | Q51070812 | ||
| A redox switch in C-reactive protein modulates activation of endothelial cells. | Q51595729 | ||
| Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP(m). | Q51717888 | ||
| Studies on the interactions between C-reactive protein and complement proteins. | Q52576446 | ||
| Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice. | Q53662602 | ||
| C-reactive protein specifically enhances platelet-activating factor-induced inflammatory activity in vivo. | Q53676541 | ||
| Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide. | Q53895846 | ||
| Dissociation of Pentameric to Monomeric C-Reactive Protein on Activated Platelets Localizes Inflammation to Atherosclerotic Plaques | Q57132361 | ||
| Localizing of C-reactive protein in synovium of patients with rheumatoid arthritis | Q67708757 | ||
| Modulation of stimulus-dependent human platelet activation by C-reactive protein modified with active oxygen species | Q68415994 | ||
| Complement activation induced by human C-reactive protein in mildly acidic conditions | Q68843776 | ||
| Immunohistochemical studies of C-reactive protein and apolipoprotein B in inflammatory and arterial lesions | Q69886670 | ||
| Localization of C-reactive protein in inflammatory lesions of experimental allergic encephalomyelitis | Q70181304 | ||
| Purification and characterization of human serum C-reactive protein | Q71145528 | ||
| Binding of model soluble immune complexes to modified C-reactive protein | Q71151738 | ||
| Binding of fibronectin by the acute phase reactant C-reactive protein | Q71260800 | ||
| Comparative analyses of pentraxins: implications for protomer assembly and ligand binding | Q72609807 | ||
| Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation | Q73083027 | ||
| Calcium-dependent and -independent binding of the pentraxin serum amyloid P component to glycosaminoglycans and amyloid proteins: enhanced binding at slightly acid pH | Q73370299 | ||
| C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis | Q74290879 | ||
| Evidence of hypoxic areas within the arterial wall in vivo | Q77297609 | ||
| Expression of rabbit C-reactive protein in transgenic mice inhibits development of antigen-induced arthritis | Q79297270 | ||
| Structural and functional comparison of native pentameric, denatured monomeric and biotinylated C-reactive protein | Q79428361 | ||
| Conduct unbecoming: C-reactive protein interactions with a broad range of protein molecules | Q80572759 | ||
| Interactions of C-reactive protein with low-density lipoproteins: implications for an active role of modified C-reactive protein in atherosclerosis | Q82075603 | ||
| Modified C-reactive protein interacts with platelet glycoprotein Ibα | Q84165501 | ||
| Immunohistochemical staining reveals C-reactive protein existing predominantly as altered conformation forms in inflammatory lesions | Q85261573 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3129-3136 | |
| P577 | publication date | 2017-01-17 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Functional Transformation of C-reactive Protein by Hydrogen Peroxide | |
| P478 | volume | 292 |
| Q90441319 | C-Reactive Protein and Its Structural Isoforms: An Evolutionary Conserved Marker and Central Player in Inflammatory Diseases and Beyond |
| Q54957842 | C-Reactive Protein as a Therapeutic Target in Age-Related Macular Degeneration. |
| Q54946647 | C-Reactive Protein in Atherothrombosis and Angiogenesis. |
| Q64078741 | Evolution of C-Reactive Protein |
| Q92405017 | Functionality of C-Reactive Protein for Atheroprotection |
| Q64092597 | Hyper-acidic fusion minipeptides escort the intrinsic antioxidative ability of the pattern recognition receptor CRP in non-animal organisms |
| Q46284091 | Redox-Sensitive Innate Immune Pathways During Macrophage Activation in Type 1 Diabetes |
| Q64100462 | Structure-Function Relationships of C-Reactive Protein in Bacterial Infection |
| Q92445757 | The Multiple Faces of C-Reactive Protein-Physiological and Pathophysiological Implications in Cardiovascular Disease |
| Q92116745 | Zinc-α2-glycoprotein as an inhibitor of amine oxidase copper-containing 3 |
Search more.